Northwest Biotherapeutics | Ativos





Ativos Alterar Data
Agenus USD 233.89M 48.67M 2025-09
AstraZeneca USD 114.07B 382M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Celldex Therapeutics USD 648.44M 43.97M 2025-09
Eisai JPY 1.49T 48.22B 2025-12
Infinity Pharmaceuticals USD 21.23M 8.72M 2023-06
Merck USD 129.55B 12.02B 2025-09
Northwest Biotherapeutics USD 30.61M 1.06M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Plus Therapeutics USD 11.39M 1.89M 2023-12
Roche Holding CHF 100.7B 5.94B 2025-12


Northwest Biotherapeutics Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.